✦ LIBER ✦

Impact of CD34+ Cell-Doses Given during Autologous Stem Cell Transplantation on Absolute Lymphocyte Recovery in Multiple Myeloma Patients

✍ Scribed by Foster, Laahn H.; Petroni, Gina; Williams, Paige G.; Volodin, Leonid; Beitinjaneh, Amer; Laughlin, Mary J.; Kindwall-Keller, Tamila L.

Book ID: 122326790
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 50 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of CD34+ cell dose on hematopoiet

Effect of CD34+ cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

✍ Jens Klaus; Doris Herrmann; Iris Breitkreutz; Ute Hegenbart; Uta Mazitschek; Ger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Transplanted CD34+ Cell Dose Is Associat

Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Recovery following Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma

✍ Patrick J. Stiff; Ivana Micallef; Auayporn P. Nademanee; Edward A. Stadtmauer; R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Viable CD34+/CD133+ blood progenitor cel

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

✍ C. Hicks; R. Wong; A. Manoharan; Y. L. Kwan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

Impact of MiRSNPs on Survival and Progre

Impact of MiRSNPs on Survival and Progression in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

✍ de Larrea, C. F.; Navarro, A.; Tejero, R.; Tovar, N.; Diaz, T.; Cibeira, M. T.; 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 556 KB

Transplantation with selected autologous

Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution

✍ Mauricette Michallet; Thierry Philip; Irène Philip; Hubert Godinot; Catherine Se 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 427 KB

CD34+ selection of autologous peripheral

CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma

✍ Dyson, P G; Horvath, N; Joshua, D; Barrow, L; Van Holst, N G; Brown, R; Gibson, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB